Trade uncertainty: Explore resources and tools for your business.
Trade uncertainty: Explore resources and tools for your business.
NeurAxon is a leader in discovering and developing next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating chronic pain and central nervous system neuronal sensitization.
BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.
To find out more, consult our Policy on confidentiality.